Bonner B, Warren B, Bucci L. Influence of ferulate supplementation on postexercise stress hormone levels after repeated exercise stress. J Appl Sports Sci Res. 1990;4:110.

Bouic, P. J. D., Etsbeth, S., Liebenberg, R.W., Albrecht, C. F, Pegel, G., Van Jaarsveld, P.P., (1996) “Beta-sitosterol and beta-sitosterol glucoside stimulate human peripheral blood lymphocyte proliferation: Implication for their use as an immunomodulatory vitamin combination.” International J. Immunopharmacology, 18(12): 693-700.

Cicero AF, Gaddi A. Rice bran oil and gamma-oryzanol in the treatment of hyperlipoproteinaemias and other conditions. Phytother Res. 2001;15:277-289.

Bucci LR, Blackman G, Defoyd W, et al. Effect of ferulate on strength and body composition of weightlifters. J Appl Sports Sci Res. 1990;4:110.

Cheruvanky, R., McPeak, P., Cherukuri, R.S, and Lynch, I. , (2000)“Method for treating hypercholesterolemia, hyperlipidemia and atherosclerosis.” US Patent 6,126,943 and US Patent 6,350,473 B1.

Fry, A.C., E. Bonner, D.L. Lewis, R.L. Johnson, M.H. Stone, and W.J. Kraemer. 1997. “The Effects of Gamma-Oryzanol Su pplementation During Resistance Exercise Training.” International Journal of Sport Nutrition 7(4): 318-329.

Hata, A., S. Koga, H. Shigematsu, S. Kato , et al. 1981. “Study on Effects of Gamma-Oryzanol on Hyperlipemia: – Multicenter Cooperative Pilot Study for Dosage Finding. Geriat. Med. 19: 1813-1840.

Hirose, M., K. Ozaki, K. Takaba, L. Fukushima, T. Shirai, and N. Ito. 1991. “Modifying Effects of the Naturally Occurring Antioxidants g-Oryzanol, Phytic Acid, Tannic Acid, and n-Tritriacontane-16, 18-Dione in a Rat Wide-Spectrum Organ Carcinogenesis Model.” Carcinogenesis 12(10): 1917-1921.

Hiramitsu, T. and D. Armstrong. 1991. “Preventive Effect of Antioxidants on Lipid Peroxidation in the Retina.” Ophthalmic Res. 23: 196-203.

Ichimaru, Y., M. Moriyama, M. Ichimaru, and Y. Gomita. 1984. “Effects of Gamma-Oryzanol on Gastric Lesions and Small Intestinal Propulsive Activity in Mice.” Nippon Yakurigaku Zasshi 84(6): 537-542.

Itaya, K., J. Kiyonaga, and M. Ishikawa. 1976. “Studies of Gamma-Oryzanol (2). The Antiulcerogenic Action.” Nippon Yakurigaku Zasshi 72(8): 1001-1011.

Itaya, K. and J. Kiyonaga. 1976. “Studies of Gamma-Oryzanol (1). Effects on Stress- Induced Ulcer.” Nippon Yakurigaku Zasshi 72(4): 475-481.

Ieiri, T., Kase, N., Hashigami, Y., Nakumura, T., Shimoda, S., (1982) “Effect of gamma oryzanol on the hypothalamo-pituitary axis in the rat.” NipponNaibunpi Gokkai Zasshi, 58(10): 1350-6.

Kahlon, T.S., F.I. Chow, M.M. Chiu , C.A. Hudson and R.N. Sayre. 1996.
“Cholesterol-Lowering by Rice Bran and Rice Bran Oil Unsaponifiable Matter in Hamsters.” Cereal Chemistry 73(1): 69-74.

Kahlon, T.S., and F.I. Chow. 1997. “Hypocholesterolemic Effects of Oat, Rice, and Barley Dietary Fibers and Fractions.” Cereal Foods World 42(2): 86-92.

Kim, J.S., J.S. Godber, J.M. King, W. Prinyawiwatkul, and H.Y. Chung. 2000. “Vitamin E Vitamers and g-Oryzanol from Rice Bran Inhibit the Formation of 7-Ketocholesterol in Aqueous Dispersion System.” (51E-1). Book of Abstracts: IFT Annual Meeting, Dallas , Texas . June 10-14.

Lichtenstein AH, Ausman LM, Carrasco W, et al. Rice bran oil consumption and plasma lipid levels in moderately hypercholesterolemic humans. Arterioscler Thromb. 1994;14:549–556.

Murase Y, Iishima H. Clinical studies of oral administration of gamma-oryzanol on climacteric complaints and its syndrome. Obstet Gynecol Prac. 1963;12:147–149.

Nippon Heikatsukin Gakkai Zasshi. 1980 Mar;16(1):47-55. Effects of gamma-oryzanol on the movements of stomach and ileum in the dog (author's transl)]

Nippon Heikatsukin Gakkai Zasshi. 1980 Mar;16(1):47-55. [Effects of gamma-oryzanol on the movements of stomach and ileum in the dog (author's transl)]

Nesaretnam, K., R. Stephen, R. Dils, and P. Darbre. 1998. “Tocotrienols Inhibit the Growth of Human Breast Cancer Cells Irrespective of Estrogen Receptor Status.” Lipids 33: 461-469.

Nicolosi, R.J., L.M. Ausman, and D.M. Hegsted. 1991. “Rice Bran Oil Lowers Serum Total and Low Density Lipoprotein Cholesterol and Apo B Levels in Nonhuman Primates”. Atherosclerosis 88: 133-142.

Ohkawa, T., Ebisuno, S., Kitagava, M., Morimoto, S., Miazaki, Y., and Yasukava, S., (1984): “Rice bran treatment for patients with hypercalciuric stones: Experimental and Clinical studies.” The Journal of Urology, 132: 1140-1145.

Qureshi, A.A., N. Qureshi, J.O. Hasler-Rapacz, F.E. Weber, V. Chaudhary, T.D. Crenshaw, A. Gapor, A.S.H Ong, Y.H. Chong, D. Peterson and J. Rapacz. 1991. “Dietary Tocotrienols Reduce Concentrations of Plasma Cholesterol, Apolipoprotein B. Thromboxane B2, and Platelet Factor 4 in Pigs with Inherited Hyperlipidemia.” Am. J. Clin. Nutr. 53: 1042S-1046S.

Quershi, A.A., N. Quershi, J.J.K. Wright, Z. Shen, A. Kramer, A. Gapor, Y.H. Chong, G. DeWitt, A.S.H. Ong, D.M. Peterson, and B.A. Bradlow. 1991. “Lowering of Serum Cholesterol in Hypercholesterolemic Humans by Tocotrienols.” Am. J. Clin. Nutr. 53: 1021S-1026.

Qureshi, A.A., Bradlow, B. A., Salser, W. A., Brace, L. D., (1997) “Novel tocotrienols of rice bran modulate cardiovascular disease risk parameters of hypercholesterolemic humans.” J. Nutrition Biochem 8: 1-9.

Qureshi, A.A., Sami, S.A., and Khan, F.A., (2002)“Effects of stabilized rice bran, its soluble and fiber fractions on blood glucose levels and serum lipid parameters in humans with diabetes mellitus Type1 and Type11." J. Nutritional Biochem 13:175-187.

Qureshi, A.A., Sami SA, Salser WA , Khan FA, (2002) “Dose-dependent suppression of serum cholesterol by tocotrienol-rich fraction (TRF(25)) of rice bran in hypercholesterolemic humans.” Atherosclerosis 2002; 161: 199-207.

Raghuram, T.C., U.B. Rao, and C. Rukmini. 1989. “Studies on Hypolipidemic Effects of Dietary Rice Bran Oil in Human Su bjects.” Nutr. Rep. Intl. 39: 889.

Nicolosi, R.J. 1991. “Health Benefits Attributed to Derivatives of Rice Bran.” Cereal Foods World 36(8): 720.

Rong N, Ausman LM, Nicolosi RJ. Oryzanol decreases cholesterol absorption.

And aortic fatty streaks in hamsters. Lipids. 1997;32:303–309.

Rosenbloom C, Millard-Stafford M, Lathrop J. Contemporary ergogenic aids used by strength/power athletes. J Am Diet Assoc. 1992;92:1264-1265.

Rong, N., L.M. Ausman, and R.J. Nicolosi. 1997. “Oryzanol Decreases Cholesterol Absorption and Aortic Fatty Steaks in Hamsters.” Lipids 32(3): 303-309.

Rukmini, C., and Raghuram, T.C., (1991) “Nutritional and biochemical aspects of the hypolipidemic action of rice bran oil: A review.” J. Amer. Coll. Nutrition. 10: 366-375.

Sasaki J, Takada Y, Handa K, et al. Effects of gamma-oryzanol on serum lipids and apolipoproteins in dyslipidemic schizophrenics receiving major tranquilizers. Clin Ther. 1990;12:263–268.

Saunders, R.M (1986) “Rice bran composition and potential food uses.” Food Rev. Int.8: 415-498.

Su gano, M., and Tsuji, E., (1997) “Rice bran oil and cholesterol metabolism.” Jl of Nutrition 127(3): 521S-524S.

Tomeo, A.C., Geller, M., Watkins, T.R., (1995) “Antioxidant effects of tocotrienols in patients with hyperlipidemia and carotid stress.” Lipids, 30: 1179.

Xu Z, Hua, N., Godber, J. S., (2001) “Antioxidant activity of tocopherols, tocotrienols, and gamma oryzanol components from rice bran against cholesterol oxidation accelerated by 2,21-azobis(2-methylpropionamideine) dihydrochloride.” J. Agric. Food. Chem, 49(4):2077-81.